Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Jun
24
Today In Oncology
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
Breast Cancer Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination With Pembrolizumab for First-Line Treatment of TNBC
Educational Gaps Found in Cardio-Oncology Training
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo